FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma (FL)
FDA approves ✔️ Tafasitamab-cxix for relapsed or refractory follicular lymphoma (FL) On June 18, 2025, The FDA has approved tafasitamab-cxix […]
Pharma Bulletin
Meijer Issues Recall on Frederik’s Dark Chocolate Almonds Due to Presence of Undeclared Cashews
Meijer Issues Recall on Frederik’s Dark Chocolate Almonds Due to Presence of Undeclared Cashews GRAND RAPIDS, Mich. – Meijer has issued
DRAP’s action on Medroxyprogesterone acetate associated meningioma risk
DRAP’s Action on Medroxyprogesterone Acetate in Response to Meningioma Concerns and US Lawsuits Amid the ongoing lawsuits in the US
LATEST DRAP RECALL ALERT OF MEDICINES
DRAP RECALL ALERT-JUNE 2025 Drug regulatory authority of Pakistan (DRAP) is responsible for the regulation of drugs and therapeutic drugs
FDA Approves Darolutamide (NUBEQA®) For Metastatic Castration-Sensitive Prostate Cancer
FDA approves Darolutamide for metastatic castration-sensitive prostate cancer FDA approves darolutamide for metastatic castration-sensitive prostate cancer on june 3, 2025.
Pharmacovigilance via VigiMobile app- Smart Reporting.
VigiMobile app, a smart way to report ADR| Core of medical profession- essential to be known by every healthcare professional| Also get to known how to download the App.
Recall Alert-Homegrown Family Foods Issues Allergy Alert on Undeclared Milk in Shore Lunch Oven Style Breader & Batter Mix
Recall Alert-Homegrown Family Foods Issues Allergy Alert on Undeclared Milk in Shore Lunch Oven Style Breader & Batter Mix Homegrown